About ERS Genomics
ers genomics was formed to commercialise the foundational crispr-cas9 intellectual property held by co-inventor, co-owner and nobel prize-winner dr. emmanuelle charpentier. licenses ... Read more
ers genomics was formed to commercialise the foundational crispr-cas9 intellectual property held by co-inventor, co-owner and nobel prize-winner dr. emmanuelle charpentier. licenses ... Read more